Correlation Between Microsoft and Perspective Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Microsoft and Perspective Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Microsoft and Perspective Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Microsoft and Perspective Therapeutics, you can compare the effects of market volatilities on Microsoft and Perspective Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Microsoft with a short position of Perspective Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Microsoft and Perspective Therapeutics.

Diversification Opportunities for Microsoft and Perspective Therapeutics

-0.09
  Correlation Coefficient

Good diversification

The 3 months correlation between Microsoft and Perspective is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Microsoft and Perspective Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Perspective Therapeutics and Microsoft is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Microsoft are associated (or correlated) with Perspective Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Perspective Therapeutics has no effect on the direction of Microsoft i.e., Microsoft and Perspective Therapeutics go up and down completely randomly.

Pair Corralation between Microsoft and Perspective Therapeutics

Given the investment horizon of 90 days Microsoft is expected to generate 0.08 times more return on investment than Perspective Therapeutics. However, Microsoft is 11.97 times less risky than Perspective Therapeutics. It trades about 0.15 of its potential returns per unit of risk. Perspective Therapeutics is currently generating about -0.26 per unit of risk. If you would invest  40,955  in Microsoft on September 2, 2024 and sell it today you would earn a total of  1,391  from holding Microsoft or generate 3.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Microsoft  vs.  Perspective Therapeutics

 Performance 
       Timeline  
Microsoft 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Microsoft are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable technical and fundamental indicators, Microsoft is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Perspective Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Perspective Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Microsoft and Perspective Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Microsoft and Perspective Therapeutics

The main advantage of trading using opposite Microsoft and Perspective Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Microsoft position performs unexpectedly, Perspective Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Perspective Therapeutics will offset losses from the drop in Perspective Therapeutics' long position.
The idea behind Microsoft and Perspective Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Bonds Directory
Find actively traded corporate debentures issued by US companies
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals